Skip to main content
. 2016 Jan 15;95(2):e2495. doi: 10.1097/MD.0000000000002495

TABLE 2.

The Overall Survival Result of Erlotinib Versus Conventional Chemotherapy for Advanced NSCLC

graphic file with name medi-95-e2495-g005.jpg